El currículo oculto y la cultura de seguridad del paciente. En @Health_Affairs http://t.co/PZNV4MAoyz #SegPac v @2gespetites
— Sano y salvo (@sanoysalvoblog) January 26, 2014
A safer healthcare system is a shared responsibility. Our poster can help you prevent medication incidents http://t.co/0DHVjKw1Ll #ptsafety
— Safe Medication Use (@SafeMedUse) January 27, 2014
Use of postmenopausal hormone replacement therapy was associated with increased risk of acute pancreatitis http://t.co/6Nsag5si6N #PtSafety
— Sano y salvo (@sanoysalvoblog) January 27, 2014
(NEJM) Choosing Wisely — The Politics and Economics of Labeling Low-Value Services http://t.co/mRXLrXHo17 #PtSafety #ChoosingWisely
— Sano y salvo (@sanoysalvoblog) January 27, 2014
Evidence-based de-implementation for contradicted,unproven and aspiring healthcare practices http://t.co/ibRwcJZZeN vía @rafabravo #PtSafety
— Sano y salvo (@sanoysalvoblog) January 27, 2014
Inhibidores de la bomba de protones (IBP), riesgos asociados a su uso en personas de edad avanzada http://t.co/tY5h4C49a8 #SegPac
— Sano y salvo (@sanoysalvoblog) January 28, 2014
(e-butlletí groc) Novedades legislativas y otras noticias de farmacovigilancia http://t.co/KIEIYJH6vs #SegPac
— Sano y salvo (@sanoysalvoblog) January 28, 2014
Una carta en la consulta con el compromiso del médico redujo el uso inapropiado de antibióticos en IRA http://t.co/1SfYsDbQev #SegPac
— Sano y salvo (@sanoysalvoblog) January 29, 2014
Nudging Guideline-Concordant Antibiotic Prescribing: A Randomized Clinical Trial | JAMA Internal Medicine http://t.co/UMuhw0Aa4M #PtSafety
— Sano y salvo (@sanoysalvoblog) January 29, 2014
Antibiotic Judo: Working Gently With Prescriber Psychology to Overcome Inappropriate Use | JAMA Internal Medicine http://t.co/WOuLvLcNDB
— Sano y salvo (@sanoysalvoblog) January 29, 2014
Síndrome de Otelo secundario a zonisamida http://t.co/4RFSfrB3ZN #SegPac
— Sano y salvo (@sanoysalvoblog) January 29, 2014
Conflicts of interest are everywhere http://t.co/9LQuwqpg5E So, what about non-financial conflicts of interest? http://t.co/bRX8PHwxBa
— Sano y salvo (@sanoysalvoblog) January 29, 2014
Clinical guidance is not designed to replace professional judgment http://t.co/twp42unnC6 #PtSafety
— Sano y salvo (@sanoysalvoblog) January 29, 2014
A consumer mistakenly swallowed a Spiriva capsule instead of using an inhaler http://t.co/BcudtHSO7C vía @SafeMedUse #PtSafety
— Sano y salvo (@sanoysalvoblog) January 29, 2014
Drug-Induced Liver Injury (review) http://t.co/Wpin1iu6Dq #PtSafety
— Sano y salvo (@sanoysalvoblog) January 29, 2014
Ophthalmic adverse drug reactions to systemic drugs: a systematic review http://t.co/b9W2LHarxn #PtSafety
— Sano y salvo (@sanoysalvoblog) January 29, 2014
(BMJ) Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study http://t.co/kOP5XnfnnF #PtSafety
— Sano y salvo (@sanoysalvoblog) January 30, 2014
Will Choosing Wisely change the way family physicians practice? http://t.co/m756W9E6os #PtSafety vía @AFPJournal
— Sano y salvo (@sanoysalvoblog) January 30, 2014
(MHRA) Cosopt preservative-free eye drops: new interim container http://t.co/yKIVqpO4G0 #PtSafety
— Sano y salvo (@sanoysalvoblog) January 30, 2014
Tiotropium and the Risk of Death in COPD (NEJM letter) http://t.co/hOaEoT9Zol #PtSafety
— Sano y salvo (@sanoysalvoblog) January 31, 2014
(NEJM) Preparing for Responsible Sharing of Clinical Trial Data http://t.co/Y12B3XeXem #PtSafety
— Sano y salvo (@sanoysalvoblog) January 31, 2014
Saxagliptin, Alogliptin, and Cardiovascular Outcomes (NEJM letter) http://t.co/iBLmHfjbZr #PtSafety
— Sano y salvo (@sanoysalvoblog) January 31, 2014
Caso Agreal: La Audiencia de Barcelona condena a Sanofi a pagar 120.000 euros a 14 mujeres http://t.co/7GRKMtpFxX #SegPac
— Sano y salvo (@sanoysalvoblog) January 31, 2014
Adaptación de instrumento de AHRQ para valorar la cultura de seguridad del paciente en residencias d ancianos http://t.co/lh0yVceGrt #SegPac
— Sano y salvo (@sanoysalvoblog) January 31, 2014
PaSQ European Union Network for Patient Safety and Quality of Care:
Good Practices wiki http://t.co/yTEr253e4X #PtSafety
— Sano y salvo (@sanoysalvoblog) January 31, 2014
(CDC) Rotavirus Vaccine Administration Errors — United States, 2006–2013 http://t.co/0QNY4Q7sTz #PtSafety
— Sano y salvo (@sanoysalvoblog) January 31, 2014
Testosterone Products: Drug Safety Communication - FDA Investigating Risk of Cardiovascular Events http://t.co/XOBXCgLOLa #FDA
— US FDA MedWatch (@FDAMedWatch) January 31, 2014
(Prescrire) Cardiac disorders with pregabalin http://t.co/Q7uJqvKBjS #PtSafety
— Sano y salvo (@sanoysalvoblog) February 1, 2014
(Prescrire) French data on the adverse effects of etoricoxib http://t.co/Q7uJqvKBjS #PtSafety
— Sano y salvo (@sanoysalvoblog) February 1, 2014
(BMJ) Testosterone therapy is associated with raised risk of myocardial infarction, US study finds http://t.co/D2NiQCgUtV #PtSafety
— Sano y salvo (@sanoysalvoblog) February 1, 2014
Evaluación preventiva d riesgos en incorporación de nuevos medicamentos a práctica asistencial:propuesta metodológica http://t.co/OK07BvIVI9
— Sano y salvo (@sanoysalvoblog) February 1, 2014
Recomendaciones para la preparación de medicamentos estériles en las unidades de enfermería http://t.co/9zDfGFgDLs válido tb para AP #SegPac
— Sano y salvo (@sanoysalvoblog) February 1, 2014
Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis http://t.co/yzWzKplav1 #PtSafety
— Sano y salvo (@sanoysalvoblog) February 1, 2014
EL NHS pone en marcha el "National Patient Safety Alerting System" http://t.co/zbixoCr8wb #PtSafety
— Sano y salvo (@sanoysalvoblog) February 1, 2014
Eventos adversos por medicamentos en menores de 18 años http://t.co/bbP2geK15i Informe de ISMP QuarterWatch (FDA 2008/2012) vía @AAFH_farma
— Sano y salvo (@sanoysalvoblog) February 2, 2014
Adverse drug events in children under age 18 http://t.co/Uj0ZdQRl9Q by ISMP QuarterWatch. FDA (2008/2012) #PtSafety pic.twitter.com/2t7arP5PG0
— Sano y salvo (@sanoysalvoblog) February 2, 2014
*El equipo que mantiene @sanoysalvoblog está compuesto por Cecilia Calvo Pita @cecilicp y Jesús Palacio Lapuente @je_pala.
Realiza la publicación de estas selecciones Txema Coll Benejam @txemacoll.
No hay comentarios:
Publicar un comentario